A Guide for the Interpretation and Reporting of Sequence Variants in Cancer
August 14, 2018
Recently we hosted a webinar in which Medical Director, Shalini Verma, and VP Product, Andy Bredemeyer, reviewed and applied the Association for Molecular Pathology (AMP) joint consensus guidelines for the interpretation and reporting of sequence
Read More
We Know Precision Medicine: Andy Bredemeyer, VP Product
July 26, 2018
"We Know Precision Medicine" is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In this article, Andy Bredemeyer, VP Product, discusses how
Read More
Less Variation, More Standardization in Somatic Variant Interpretation and Reporting
July 13, 2018
Preparing for our upcoming webinar -- A Practice-based Guide for Interpretation and Reporting of Sequence Variants in Cancer--caused us to think about the evolution of next generation sequencing (NGS) into the clinic and how there’s hasn't been a
Read More
We Know Precision Medicine: Rakesh Nagarajan
June 27, 2018
"We Know Precision Medicine" is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In this first article, Rakesh Nagarajan, Founder and Executive
Read More
PierianDx Expands to Australia with Addition of Anatomical Pathology PathWest Laboratory Medicine
June 11, 2018
PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that the Department of Anatomical Pathology PathWest Laboratory Medicine will use the company’s Clinical Genomics WorkSpace™ (CGW) platform,
Read More
2bPrecise and PierianDx Collaborate to Deliver a Comprehensive Precision Medicine Solution
June 1, 2018
As posted on BusinessWire
Read More
PierianDx Hires Healthcare IT, Analytics Pioneer as CEO
May 23, 2018
MAY 24, 2018 -- ST. LOUIS -- PierianDx, the leader in clinical genomics solutions, announced today that it has appointed Michael L. Sanderson as Chief Executive Officer and Director of the Board. In his new role, Sanderson will execute on the
Read More
PierianDx Partners with ScienceVision to Bring Robust Precision Medicine Support to Southeast Asia
May 13, 2018
MAY 14, 2018 -- ST. LOUIS -- PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that it has executed a distribution agreement with ScienceVision, a leading provider of end-to-end genomic
Read More
University of Alabama takes a Dogged Approach to Precision Medicine
April 19, 2018
In the U.S. alone, there are nearly 700,000 people living with a primary brain tumor. And each year, there are nearly 70,000 new diagnoses and 17,000 deaths. [1] With over 120 different types of tumors and a tricky blood-brain barrier to permeate,
Read More
PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International
April 17, 2018
PierianDx, the leading genomics technology companythat enables precision medicine,announced today a strategic partnership with RTI International to help solve the problem of translating complex genomic data into actionable clinical insight to
Read More
